Background and Purpose: Mobility problems are common among older adults. Symptomatic lumbar spinal stenosis (SLSS) is a major contributor to mobility limitations among older primary care patients. In comparison with older primary care patients with mobility problems but without SLSS, it is unclear how mobility problems differ in older primary care patients with SLSS. The purpose of this study was to compare health characteristics, neuromuscular attributes, and mobility status in a sample of older primary care patients with and without SLSS who were at risk for mobility decline. We hypothesized that patients with SLSS will manifest poorer health and greater severity of neuromuscular impairments and mobility limitations.
INTRODUCTION
Symptomatic lumbar spinal stenosis (SLSS) is a common cause of mobility limitations among older adults. [1] [2] [3] [4] Diffi culty walking, climbing stairs, and rising from a chair are examples of mobility limitations, which are experienced by as many as 25% of adults 70 years and older. [5] [6] [7] Performance of these mobility tasks commonly worsens with aging, but more so for older adults with SLSS. [8] [9] [10] SLSS is defi ned as the presence of radiographic lumbar spinal stenosis (LSS) and characteristic self-reported symptoms. Radiographic LSS is a progressive and degenerative spine disorder causing anatomic narrowing of the central spinal canal, neuroforamina, and/or lateral recess. [1] [2] [3] [4] The hallmark symptom of SLSS is the presence of neurogenic claudication, defi ned as pain, numbness, and/or weakness in either lower extremity that worsens with walking and lessens with spinal fl exion postures. 9 The presence of neurogenic claudication is a major contributor to limitations in mobility. 2 , 4 In addition, older adults with SLSS may manifest multiple comorbidities, more so than those without SLSS, that contribute further to greater limitations in mobility. 11 Substantive research exists on the operative management of SLSS, which has modest outcomes regarding mobility performance. [12] [13] [14] [15] However, there is no agreement on which interventions or combination of interventions is optimal for the nonsurgical management of SLSS. 3 , 13 While the nonsurgical evidence base is weak, there is a general agreement that treatment should involve rehabilitative exercise. 3 , 13 A fundamental principle in developing rehabilitative exercises for patients with SLSS is that the underlying neuromuscular impairments that limit mobility should be corrected or mitigated to improve mobility skills and optimize the individual's participation in life roles. 16 The link between reduction in impairments and improvements in activities and participation is well conceptualized within the International Classifi cation of Functioning, Disability and Health . 16 , 17 However, at this point in time, the neuromuscular impairments that are characteristic of SLSS have not been well described, especially in comparison with older adults with mobility problems from other causes. As a result, there is a lack of available evidence to guide the development of effi cacious treatment plans for patients with SLSS. 3 , 13 While impairment-based treatments are being developed for older adults with mobility problems in general, there is little or no information on whether these same treatment paradigms should also be applied to patients with SLSS. 18 Furthermore, much of the existing research addressing mobility limitations has focused mostly on walking and does not address the broader range of activities that encompass mobility skills. 1 , 19-21 To address these knowledge gaps, a secondary analysis of the Boston Rehabilitative Impairment Study of the Elderly (Boston RISE) was conducted. The aims of this study were to compare (1) health characteristics, (2) neuromuscular attributes, and (3) mobility status among older primary care patients with and without SLSS who are at risk for mobility decline. It was hypothesized that older primary care patients with SLSS would manifest poorer health and greater severity of neuromuscular impairments and mobility limitations.
METHODS
This study is a secondary analysis of data from Boston RISE. Boston RISE is a longitudinal cohort study of 430 older primary care patients who are at risk for mobility decline, as defi ned by self-reported diffi culty or the inability to walk 0.5 mile or climb 1 fl ight of stairs without assistance. It includes measures of 11 neuromuscular attributes Research Report as well as self-reported and performance-based measures of mobility across a large range of functional tasks including walking capacity. 22 Patients were recruited from primary care practices with the following inclusion criteria: age 65 years or more and an ability to communicate and understand English. Patients excluded were those with terminal illness, major surgery or myocardial infarction in the past 6 months, a planned major surgery, a planned move from the Boston area within 2 years, major medical problems that would interfere with safe and successful testing, a MiniMental State Examination score of less than 18, and a Short Physical Performance Battery (SPPB) score of less than 4. 22 Boston RISE also contains questions that have been identifi ed as components of the clinical defi nition of SLSS. 9 All study procedures for Boston RISE were approved by the appropriate institutional review board. The rights of human subjects were protected, and informed consent was received for all participants.
SLSS has been defi ned as the presence of radiographic LSS as evidenced on cross-sectional imaging and characteristic self-reported lower extremity symptoms such as neurogenic claudication. 7 For inclusion in this secondary analysis, participants must have undergone a computerized tomography (CT) scan of the lumbar spine and completed the questionnaire with components of the clinical defi nition of SLSS, that is, neurogenic claudication. The presence of neurogenic claudication was ascertained according to the participant's self-report of pain, numbness, and/or weakness in either lower extremity that increases with walking and decreases with bending forward or sitting down or resolves upon sitting. 9 , 23 Although imaging was not part of the primary aims of Boston RISE, a separate ancillary study of Boston RISE was conducted by different authors among 51 participants and included CT scans of the lumbar spine that were used for this study. 24 Additional criteria for the current study included completion of measures of neuromuscular attributes and self-reported and performancebased mobility. On the basis of these criteria, of the 430 participants from Boston RISE, 50 participants met the inclusion criteria.
Boston RISE conducted assessments over 2 years of follow-up. The CT scan study containing radiographic evidence of LSS was conducted at different stages of follow-up for the 50 participants in this secondary analysis. Assessment data from the annual visit closest to the referent CT scan were used. If measures of neuromuscular attributes or mobility were missing for that visit, then the most recent available measures were used for analysis. Fortythree of 50 participants had complete data available at the time the CT scan was conducted. Seven participants did not have complete data with regard to certain physiologic and performance-based measures at the time of the CT scan because tests were not performed for safety reasons or participants refused. Data from the most recent follow-up assessment were analyzed for these participants.
CT scans evaluated the lumbar spine levels from L2 to S1. All scans were read by a spine physiatrist (P.S.) trained in the assessment of lumbar spine CT scans for research purposes. The reader was blinded to clinical information including the results of the SLSS questions. Grading of central canal and neuroforaminal stenosis was conducted using established grading systems that have been well described previously. 23 , 25 , 26 The presence of radiographic LSS was evaluated and graded at the central canal, and the right and left neural foramina, using a categorical classifi cation system. Central canal stenosis was graded according to the degree of narrowing for the cross-sectional area of the central canal. Narrowing of one-third or less of the normal cross-sectional area was classifi ed as mild stenosis; between one-third and two-third narrowing as moderate stenosis; and greater than two-thirds narrowing as severe stenosis. 25 Neuroforaminal stenosis was assessed using sagittal CT reformations and graded qualitatively based on the area of the foramina and the degree of deformity of the epidural (perineural) fat, surrounding the nerve root. 26 A normal neural foramen was defi ned by the classic oval or inverted pear-shaped appearance. 26 Mild neuroforaminal stenosis included slight narrowing of the foramina due to bony stenosis or intervertebral disc changes and/or mild effacement of the perineural fat, but with fat still completely surrounding the nerve root. Moderate neuroforaminal stenosis included deformity of the perineural fat, with perineural fat only partially surrounding the nerve root. Severe foraminal stenosis included circumferential obliteration of the perineural fat. Lateral recess stenosis was not examined as part of this study because of the lack of consensus on optimal grading systems and poor reliability in prior studies. 27 Participants with self-reported neurogenic claudication symptoms and the presence of moderate to severe central canal stenosis or severe neuroforaminal stenosis, evidenced by CT scan, were classifi ed as having SLSS. 9 Participants with self-reported neurogenic claudication symptoms, but without moderate to severe central canal stenosis or severe neuroforaminal stenosis, were classifi ed as not having SLSS. Participants without self-reported neurogenic claudication symptoms regardless of radiographic fi ndings were classifi ed as not having SLSS.
Selected health characteristics from Boston RISE were used for this study including age, gender, comorbidities, body mass index, cognitive status, and global pain. The number of comorbidities was ascertained from a validated self-reported questionnaire developed by Sangha and colleagues. 28 It includes questions about the presence of a broad range of chronic conditions. 28 Body mass index was calculated as weight (kg)/height 2 (m 2 ). 29 Cognitive status was measured using the Mini-Mental State Examination score. 30 Global pain was evaluated using the Brief Pain Inventory Pain Severity subscale, with the fi nal score (0-10) comprising an average of 4 self-reported pain ratings: pain at its worst in the last week, at its least in the last week, on average, and at its current status. 31 Eight neuromuscular attributes from the Boston RISE assessment were evaluated (trunk extensor endurance, limb strength, limb speed, limb strength asymmetry, ankle range of motion [ROM] , knee ROM, kyphosis, and sensory loss). Trunk extensor endurance was measured using a specialized plinth that stabilized the participant's pelvis and lower extremities in a position 45 ° from a horizontal plane. Trunk extensor endurance was recorded as the time in seconds that a participant could maintain a neutral trunk position with arms crossed over his or her chest (0-150 seconds). 7 Limb strength and limb speed were measured using a pneumatic leg press. Limb measures represent the composite lower extremity including the hip, knee, ankle, and foot. The 1 repetition maximum was conducted for both lower extremities. The higher value of either lower extremity was recorded as the 1 repetition maximum and normalized on the basis of body weight (newtons per kilogram). Limb speed was measured in meters per second and derived from the participant's maximum limb power measure. 32 Limb speed corresponds to the speed of movement of the lower extremity as measured on the pneumatic leg press. Limb strength asymmetry was measured as the ratio of the higher value of a participant's right or left side divided by the lower value of the opposing side. Lower extremity ROM was measured using a goniometer and based on standardized protocols. 33 Impaired ankle ROM (yes/no) was recorded as the inability to dorsifl ex past neutral (0°) or more or the inability to plantarfl ex greater than 20 ° on either lower extremity. Maximum knee fl exion ROM was recorded with the participant positioned in the supine position and measured in degrees.
In addition, kyphosis was measured using a fl exicurve ruler placed over the participant's thoracic spine. The curvature of the ruler was then traced onto a paper, and a measure of height/length × 100 was recorded for the amount of thoracic kyphosis. 34 Sensory loss (yes/no) was measured using the Semmes-Weinstein monofi lament test and assessed over the dorsum of the right and left great toes proximal to the nail bed. Sensory loss was recorded if a participant was unable to feel less than 3 of 5 touches for both, the 5.07 and 4.17 monofi laments on one or both toes. 35 Three neuromuscular attributes were not used for this pilot study. Knee fl exion and extension ROM asymmetry and knee extension ROM were excluded from analysis because of a high level of covariance among these variables. Maximum knee fl exion ROM was used to represent the attribute for knee ROM.
Mobility was evaluated using both self-reported and performance-based measures conducted at the closest annual visit to the CT scan. These measures were selected to represent assessment of a broad spectrum of tasks that make up mobility, beyond just walking. Self-reported mobility was measured using the Late-Life Function and Disability Instrument. 36 Within this instrument, functional mobility tasks are categorized into 3 domains: upper extremity function, basic lower extremity (BLE) function, and advanced lower extremity (ALE) function. Our analysis included the BLE and ALE domains, which best correspond to lower extremity mobility tasks. Each domain is calibrated on a 0 to 100 scale, with higher scores indicating better functional mobility.
Performance-based mobility limitations were measured using the following tools: the SPPB 37 ; habitual gait speed (HGS) 38 ; and the 400-m walk test. 39 The SPPB comprises 3 tests: standing balance, usual paced walking speed, and a 5-repetition chair stand. Each of the 3 tests is scored from 0 to 4, with the total score being a sum of the 3 tests (0-12), and a higher score indicating better performance. HGS, measured in meters per second, was derived from the usual walking speed subcomponent of the SPPB, which measures the time it takes to walk 4 m. The 400-m walk test is measured in minutes as the time it takes to walk 400 m as quickly as possible, up to a maximum of 15 minutes. All measures are reliable and valid measures among older adults. 5 , 37 , 38 , 40-43 Descriptive statistics were obtained for both the SLSS and no-SLSS groups using medians and interquartile ranges for continuous variables and frequencies with percentages for categorical variables. For the comparison of health characteristics (aim 1), Wilcoxon rank sum tests for continuous data were employed. Nonparametric statistics were used because of the non-normal distribution of the data and the inequality of the number of subjects within groups. The χ 2 test was used to compare categorical data. The same approach was utilized for comparison of neuromuscular attributes (aim 2) as well as mobility measures (aim 3). An α level of .05 was used to determine statistical signifi cance. SAS 9.3 (SAS Institute Inc, Cary, North Carolina) was used for statistical analyses.
RESULTS
Of the 50 participants, 5 (10%) met criteria for manifesting SLSS. Signifi cant differences in health characteristics were observed for median number of chronic illnesses [SLSS: 7.0 (2.0) vs no-SLSS: 4.0 (2.0), P < .001] and median global pain [SLSS: 3.0 (2.5) vs no-SLSS: 1.75 (2.25), P = .008] for participants with and without SLSS ( Table 1 ) .
Median knee ROM limitation was signifi cantly greater among participants with SLSS than among those without SLSS [SLSS: 115.0 ° (8.0 ° ) vs no-SLSS: 126.0 ° (10.0 ° ), P = .04] ( Table 2 ) . No other statistically signifi cant differences were observed among neuromuscular attributes between those with and without SLSS.
Participants with SLSS had signifi cantly lower median self-reported scores on the ALE subscale of the Late-Life Function and Disability Instrument than participants without SLSS [SLSS: 33.12 (2.83) vs no-SLSS: 45.81 (16.35), P = .03]. No signifi cant differences were reported in BLE function or in performance-based mobility measures between participants with and without SLSS ( Table 3 ) .
DISCUSSION
The major fi ndings of this pilot study illustrate that older primary care patients who are at risk for mobility decline with SLSS manifest important differences in health characteristics, knee ROM, and mobility when compared with a similar sample without SLSS.
Research Report
The 5 older primary care patients with SLSS experienced a higher level of pain and more comorbidities than those without SLSS. Despite the small number of subjects with SLSS, these fi ndings are consistent with previous studies conducted on older adults with SLSS. Battie and colleagues 11 reported greater comorbid conditions for a community-based sample of 245 adults with SLSS and a mean age of 65 years. In that study, those with SLSS had a greater number of comorbidities (mean = 3.1) than those without (mean = 1.4). While our measure of comorbidities was different, we also saw a similar magnitude of difference, which was almost 2-fold greater for those with SLSS as compared to those without (7.0 vs 4.0 conditions).
Participants with SLSS reported greater median global pain than those without SLSS. Although the difference in median global pain was relatively small (1.25 points on a 10-point scale), pain severity as measured by the Brief Pain Inventory is predictive of incident decline in mobility skills and disability among community-dwelling older adults. 45 This fi nding can be useful when prioritizing interventions that target mobility for patients with SLSS.
Older primary care patients with SLSS demonstrated signifi cantly greater limitations in ALE function. While the difference between groups on the other mobility outcome measures did not reach statistical signifi cance, all of the observed differences were in the direction of greater mobility limitation for the SLSS group and the differences were of a magnitude that could be clinically relevant. Specifi cally, minimal clinically important differences for the 400-m walk test, HGS, and the SPPB have been reported ( Table 4 ) . [46] [47] [48] The differences in performance of the 400-m walk test, HGS, and the SPPB among participants with SLSS and without SLSS surpassed minimal clinically important differences. For the BLE and ALE function measures, statistically relevant magnitudes have also been defi ned. The minimal detectable change based on a 90% confi dence interval (MDC 90 ) are reported to be 4.38 and 6.31 out of 100 for BLE function and ALE function, respectively. 49 Also, observed and clinically meaningful differences in mobility extended beyond just walking skills, which are the type of mobility limitation most classically associated with SLSS. 8 Thus, despite limitations in sample size, the fi ndings of this study highlight that while all participants were at risk for mobility decline based on the study selection criteria, those with SLSS trended toward more clinically meaningful limitations within a wide range of mobility skills than those without SLSS.
It is important to note that participants with SLSS had a greater limitation in knee fl exion ROM than participants without SLSS. A possible explanation for the greater limitation of knee fl exion is a muscle length impairment of the quadriceps musculature based on the compensatory posture assumed by individuals with SLSS. 50 , 51 Another explanation is that rates of knee osteoarthritis may have been higher among those with SLSS. Unfortunately, Boston RISE does not include adjudication of knee osteoarthritis within its assessment methods, so the infl uence of osteoarthritis on the fi ndings could not be evaluated.
Limitations of this pilot study included the small sample size and unequal distribution between those with (n = 5) and without (n = 45) SLSS, leading to a lack of power to identify additional potential statistically signifi cant differences (type II error) among measures of neuromuscular attributes and mobility. While we only observed statistically signifi cant differences in knee ROM, among the neuromuscular attributes, we did observe potentially important median differences in certain attributes in which statistically signifi cant differences were not observed. For example, participants with SLSS scored 48% lower on the trunk extensor muscle endurance test. This fi nding is consistent with a previous study that demonstrated decreased trunk extensor muscle endurance among older primary care patients with low back pain. 52 This fi nding can be useful when selecting targeted interventions for patients with SLSS.
Another limitation of this study is that Boston RISE participants are not necessarily representative of all primary care patients since the inclusion criteria required older age ( ≥ 65 years) and being at risk for mobility decline. Although these criteria might be expected to lead to a high prevalence of SLSS in Boston RISE, only 10% of subjects in the current sample had SLSS. However, this prevalence is consistent with that reported in a recent population-based study of older Japanese adults, which found the prevalence of SLSS ranging from 10% to 14% in men and women older than 60 years. 53 Finally, data assessments for this study were limited to a subset of participants who had CT scans performed as part of an ancillary study of Boston RISE. In addition to the CT scan, participants completed a measure of trunk extensor strength. The sample of 50 represents those older primary care patients who were willing to participate in the trunk extensor strength measure and have a CT scan of the lumbar spine. The inclusion criteria of the CT scan study may not have appealed to all Research Report participants of Boston RISE because of symptoma or safety concerns in performing the strength measure. Therefore, the participants used for this secondary analysis may not be fully representative of the entire Boston RISE cohort. Despite these limitations, this study may contribute to our understanding of SLSS. The study compared several measures of neuromuscular attributes and mobility that are commonly evaluated by physical therapists and potentially amendable to rehabilitative care. The differences in mobility in the participants with SLSS extended beyond just walking, the task most commonly limited in SLSS, and may inform physical therapists' approach to care for those with SLSS. Findings from this pilot study should be confi rmed within a larger and more representative sample of patients with SLSS. However, this line of investigation helps clarify the scope of mobility limitations among patients with SLSS and provides a basis for future studies that may identify the patterns of impairment and mobility limitations that may manifest in patients with SLSS and provide a foundation for developing intervention strategies that may reduce mobility limitations in this population.
CONCLUSION
Older primary care patients with SLSS experience greater pain, comorbidities, and greater limitation in knee ROM and mobility when compared to those without SLSS. These fi ndings may help guide future research on potential rehabilitative targets for improving mobility in older patients with SLSS.
